This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Alan Mcgown: Innovator in Cancer Treatment
Introduction
Alan Mcgown is a notable inventor based in Great Britain, recognized for his contributions to the field of cancer treatment. His work primarily focuses on quinone compounds, which have shown promising therapeutic activity, particularly in anticancer applications.
Latest Patents
Alan Mcgown holds a patent titled "Quinone Compounds And Their Uses For The Treatment Of Cancer." This patent describes quinone compounds that possess useful therapeutic activity, including anticancer properties. The patent outlines the use of these compounds and compositions in the treatment of cancer, highlighting their potential in medical applications.
Career Highlights
Throughout his career, Alan has been associated with Onco-Nx Limited, a company dedicated to advancing cancer treatment through innovative research. His work has contributed to the understanding and development of therapeutic agents that target cancer cells effectively.
Collaborations
Alan has collaborated with notable colleagues, including John Hadfield and John Butler, who share a commitment to advancing cancer research and treatment methodologies.
Conclusion
Alan Mcgown's innovative work in the field of cancer treatment, particularly through his research on quinone compounds, showcases his dedication to improving therapeutic options for patients. His contributions are significant in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile